Inhibiting RRM2 to enhance the anticancer activity of chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibiting RRM2 to enhance the anticancer activity of chemotherapy

Published:2021-01 Issue: Volume:133 Page:110996
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhan Yaqiong,Jiang Lushun,Jin Xuehang,Ying Shuaibing,Wu Zhe,Wang Li,Yu Wei,Tong Jiepeng,Zhang Li,Lou Yan,Qiu Yunqing

Funder

Science and Technology Department of Zhejiang Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference97 articles.

1. Structure of ribonucleotide reductase protein R1;Uhlin;Nature,1994

2. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage;Tanaka;Nature,2000

3. Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells;Pontarin;Proc. Natl. Acad. Sci. U. S. A.,2012

4. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies;Aye;Oncogene,2015

5. Targeting ribonucleotide reductase for cancer therapy;Shao;Expert Opin. Ther. Targets,2013

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma;Current Gene Therapy;2025-04

2. HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma;Cell & Bioscience;2024-09-10

3. Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish;Leukemia;2024-08-13

4. OXPHOS TARGETING OF MYCN-AMPLIFIED NEUROBLASTOMA;2024-08-06

5. Inhibitors of the tyrosine kinases FMS-like tyrosine kinase-3 and WEE1 induce apoptosis and DNA damage synergistically in acute myeloid leukemia cells;Biomedicine & Pharmacotherapy;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3